North Capital’s Cardinal Health CAH Stock Holding History

North Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-600	Closed	-$94.2K	–	175
2025 Q3	$94.2K	Sell	600 -3	-0.5%	-$463	0.07%	157
2025 Q2	$101K	Hold	603	–	–	0.09%	136
2025 Q1	$83.1K	Buy	+603	New	+$76.9K	0.08%	150

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

North Capital's CAH Position: Q4 2025 in Review

North Capital sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 600 shares — an estimated $94.2K sold.

North Capital first reported a position in CAH in Q1 2025 and held it in 3 quarters. The position peaked at $101K in Q2 2025. 1,411 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

North Capital reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
North Capital sold 600 Cardinal Health shares in Q4 2025, an estimated $94.2K.
North Capital first reported a position in Cardinal Health in Q1 2025 and held it in 3 quarters.
North Capital's Cardinal Health position peaked at $101K in Q2 2025.
1,411 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.